Category Archives: AZBio News
BIO – The Week That Was for Nov 13th
|
|
| BIO Actions & Activities |
C-Path’s Polycystic Kidney Disease Outcomes Consortium Secures EMA Qualification Opinion for Enrichment Biomarker in ADPKD
The Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) rendered a positive qualification opinion to C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) for total kidney volume (TKV) as a prognostic biomarker to select patients for clinical trials of new therapies for Autosomal Dominant Polycystic Kidney Disease (ADPKD).Continue reading
2016 Healthcare Technologies & Health Services Trade Mission to Saudi Arabia and Kuwait
The United States Department of Commerce is organizing a Healthcare Technologies & Health Services Trade Mission April 23-28, 2016 to the cities of Riyadh and Jeddah in the Kingdom of Saudi Arabia and Kuwait City, Kuwait.Continue reading
Prevention of Macular Degeneration Seen as Possible
UA-led research published online in the American Journal of Medicine found that the sight-destroying eye disease is delayed or prevented by l-dopa, used to treat Parkinson’s disease.Continue reading
Two new I‐Corps™ at NIH cohorts in 2016
Apply to PA-16-019 by December 10, 2016 (1st cohort) Or March 21, 2016 (2nd cohort)Continue reading
TGen Executive Named to Advisory Board for Pinnacle Transplant Technologies
Jim Harris, Vice President of Business Development for Translational Genomics Research Institute (TGen), joins other bioscience and business leaders who will support the executive team of the Phoenix-based regenerative medical company.Continue reading
Going Global: The Lung Cancer Test licensed for distribution in India
Virtual Reality makes a Real Impact on Life Sciences
Making LIFE Better: Using Vision4D and Oculus Rift virtual reality technology, arivis allows researchers to place themselves inside a brain and look around at the infinitely complex world of neurons, dendrites, and the connectomeContinue reading